Oxipit Revenue and Competitors

Vilnius,

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Oxipit's estimated annual revenue is currently $1.5M per year.(i)
  • Oxipit's estimated revenue per employee is $84,000

Employee Data

  • Oxipit has 18 Employees.(i)
  • Oxipit grew their employee count by -10% last year.

Oxipit's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M4N/AN/AN/A
#2
$3.4M307%N/AN/A
#3
$27M17526%N/AN/A
#4
$7.7M610%N/AN/A
#5
$175.6M877-6%$91.2MN/A
#6
$1.5M18-5%N/AN/A
#7
$2M20N/AN/AN/A
#8
$0.2M3-70%N/AN/A
#9
$32M20841%N/AN/A
#10
$1.3M16-33%N/AN/A
Add Company

What Is Oxipit?

Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit is the authors of CE certified multi-award winning ChestEye radiology imaging suite.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.5M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oxipit News

2022-04-06 - Meet ‘ChestLink’, The First Autonomous AI Medical Imaging Application by ‘Oxipit’ That Received CE Mark Approval in the EU

https://oxipit.ai/; https://www.theverge.com/2022/4/5/23011291/imaging-ai-autonomous-chest-xray-eu-fda...

2022-04-06 - Autonomous X-ray-analyzing AI is cleared in the EU

Oxipit spokesperson Mantas Miksys told The Verge that the company plans to file with the FDA as well. The FDA has cleared autonomous AI devices...

2022-03-30 - Oxipit Awarded CE Mark For The First Autonomous AI Medical Imaging Application

ChestLink showcases the future of healthcare diagnostics, where AI operates as an integral part of the clinical workflow”, - says CEO of Oxipit...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A1813%N/A
#2
$2.1M19-10%N/A
#3
$1.7M19-17%N/A
#4
$2M2018%N/A
#5
$2.3M200%N/A